AlphaYouFDMT: Bizily Scott discloses securities transactions
By AlphaYouPublished Form 4
Bizily Scott
Reporting filer
Bizily Scott reported Exercise or conversion in 4D Molecular Therapeutics, Inc.: 1635 units of Common Stock, dated 2026-09-16. The full Form 4 contains 3 transaction entries.
- Disclosed
- Sep 22, 2026
Reported details
3 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Bizily Scott | 2026-09-16 | M | Exercise or conversion | 1635 | 4.14 | 10,252 | 6 days | Filed terms
|
| Common Stock | Bizily Scott | 2026-09-16 | S | Sale | 1635 | 13.65 | 8,617 | 6 days | Filed terms
|
| Stock Option (Right to Buy) (derivative) | Bizily Scott | 2026-09-16 | M | Exercise or conversion | 1635 | 0 | 58,066 | 6 days | Filed terms
|
Common Stock
- Owner
- Bizily Scott
- Date
- 2026-09-16
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 1635
- Price
- 4.14
- Following holdings
- 10,252
- Reporting delay
- 6 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-16
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: false
- transaction Shares: 1635
- transaction Price Per Share: 4.14
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 10252
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Bizily Scott
- Date
- 2026-09-16
- Code
- S
- Action
- Sale
- Quantity
- 1635
- Price
- 13.65
- Following holdings
- 8,617
- Reporting delay
- 6 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-16
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 1635
- transaction Price Per Share: 13.65
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 8617
- direct Or Indirect Ownership: D
Stock Option (Right to Buy) (derivative)
- Owner
- Bizily Scott
- Date
- 2026-09-16
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 1635
- Price
- 0
- Following holdings
- 58,066
- Reporting delay
- 6 days
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 4.14
- transaction Date: 2026-09-16
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: false
- transaction Shares: 1635
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F2
- expiration Date: 2035-03-05
- underlying Security Title: Common Stock
- underlying Security Shares: 1635
- shares Owned Following Transaction: 58066
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Bizily Scott: Chief Legal Officer.
- The filing reports a Rule 10b5-1 trading plan.
- F1: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on January 13, 2026.
- F2: The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of March 6, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.
Original sources
Prepared automatically from public filing data. Report a correction.